RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors

Clinical trial NCT00576680 · COMPLETED

Trial details

NCT number: NCT00576680
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Neuroendocrine Tumor

Start date: 2008-05-01
Primary completion: 2019-03-29
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.